1. A digital picture system comprising:
a field unit comprising a digital camera;
a data server;
a proxy server; and
a client comprising a display, wherein
the data server is communicatively coupled to the field unit and to the proxy server;
the field unit comprises instructions for sending to the data server digital picture data associated with a digital picture taken by the digital camera;
the proxy server is communicatively coupled to the client;
the client comprises instructions for:
sending to the proxy server client display data indicative of a capability of the client display to display images; and
sending requests for digital picture data to the proxy server, and
the proxy server comprises instructions for:
storing the client display data;
receiving a request for digital picture data from the client;
obtaining the digital picture data from the data server in response to the request for digital picture data from the client;
transposing the digital picture data to reduce information density of the digital picture data in accordance with the stored client display data; and
transmitting the digital picture data with reduced information density to the client.
2. The system of claim 1, wherein the field unit further comprises instructions for emailing the digital picture data to the data server.
3. The system of claim 1, wherein the data server is communicatively coupled to the Internet.
4. The system of claim 1, wherein the proxy server comprises instructions for transmitting the digital picture data to the client over the Internet.
5. The system of claim 1, wherein the client display data comprises information selected from the group consisting of a display type, a display size, and a display resolution.
6. The system of claim 1, wherein the client display data is associated with a client identifier, wherein the request for digital picture data comprises the client identifier, and wherein the instruction for transposing the digital picture data to reduce information density of the digital picture data in accordance with the stored client data comprises instructions for:
comparing the client identifier sent in the request for digital picture data to other client identifiers stored in the proxy server;
selecting client display data associated with the client identifier sent in the request; and
transposing the digital picture data using the selected client display data.
7. The system of claim 1, wherein the proxy server further comprises instructions for simplifying a protocol associated with the digital picture data, and wherein the digital picture data with reduced information density transmitted from the proxy server is received by the client according to the simplified protocol.
8. The system of claim 1, wherein the field unit further comprises a microphone and wherein the field unit comprises instructions for sending to the data server audio data received by the microphone.
9. The system of claim 8, wherein the client further comprises instructions for:
sending to the proxy server client sound data indicative of a functional capability of the client to reproduce sound; and
sending a request for audio data to the proxy server; and
the proxy server further comprises instructions for:
storing the client sound data;
receiving a request for audio data from the client;
obtaining the audio data from the data server in response to the request for audio data from the client;
transposing the audio data to reduce information density of the audio data in accordance with the stored client sound data; and
transmitting the audio data with reduced information density to the client.
10. The system of claim 1, wherein the client comprises a display and a processor, and wherein the processor comprises instructions for displaying the digital picture data in each of a plurality of user-selectable display modes.
11. The system of claim 1, wherein the client further comprises instructions for displaying the digital picture data with reduced resolution such that the digital picture may be displayed entirely on the display.
12. The system of claim 1, wherein the client further comprises instructions for processing the digital picture data to display a portion of the digital picture and for receiving user input to pan over the digital picture.
13. The system of claim 1, wherein the client further comprises instructions for displaying a portion of the digital picture and for receiving user input to zoom into or out of the digital picture.
The claims below are in addition to those above.
All refrences to claim(s) which appear below refer to the numbering after this setence.
1. A compound which is represented by Formula II(b) or II(c)
wherein R4, R5 and R6 are independently hydrogen, hydroxyl, optionally substituted alkoxyl, optionally substituted thioalkoxy, optionally substituted lower alkenyl, optionally substituted low alkynyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarakyl, \u2014(C)qNHS(O)2Rc, or \u2014(C)r(X)NHRd;
wherein at least one R4, R5, or R6 is not hydrogen;
wherein Rc, and Rd are independently hydrogen, halo, hydroxyl, optionally substituted alkoxyl, optionally substituted thioalkoxy, optionally substituted alkyl, optionally substituted lower alkenyl, optionally substituted low alkynyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarakyl;
X=O or S; and
q, r=0, 1, or 2.
2. The compound of claim 1, wherein R4, R5 and R6 are independently hydrogen, or \u2014(C)qNHS(O)2Rc.
3. The compound of claim 1 or 2, wherein Rc, and Rd are independently phenyl or naphthyl, optionally substituted with 1 to 3 groups selected from the group consisting of halo, optionally substituted lower alkyl, optionally substituted alkoxyl and optionally substituted aryloxy.
4. A compound which is represented by Formula III
wherein R7 is hydrogen, halo, hydroxyl, optionally substituted alkoxyl, optionally substituted thioalkoxy, optionally substituted alkyl, optionally substituted lower alkenyl, optionally substituted low alkynyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarakyl, \u2014(C)mNHC(X)NH(C)nRa\u2014, \u2014(C)pNHC(X)Rb\u2014, \u2014(C)qNHS(O)2Rc, \u2014(C)r(X)NHRd\u2014, or \u2014(C)sNH(C)tRe;
wherein Ra, Rb, Rc, Rd and Re are independently hydrogen, halo, hydroxyl, optionally substituted alkoxyl, optionally substituted thioalkoxy, optionally substituted alkyl, optionally substituted lower alkenyl, optionally substituted low alkynyl, optionally substituted cycloalkyl, optionally substituted heterocycloalkyl, optionally substituted aryl, optionally substituted aralkyl, optionally substituted heteroaryl, optionally substituted heteroarakyl;
X=O or S; and
m, n, p, q, r, s, t=0, 1, or 2.
5. The compound of claim 4, wherein R7 is independently hydrogen, optionally substituted lower alkyl, \u2014(C)mNHC(X)NH(C)nRa\u2014, \u2014(C)pNHC(X)Rb\u2014, \u2014(C)qNHS(O)2Rc, or \u2014(C)5NH(C)tRe.
6. The compound of claim 4 or 5, wherein Ra, Rb, Rc, Rd and Re are independently phenyl or naphthyl, optionally substituted with 1 to 3 groups selected from the group consisting of halo, optionally substituted lower alkyl, optionally substituted alkoxyl and optionally substituted aryloxy.
7. The compound of claim 4, which is one of the compounds
8. A pharmaceutical composition comprising a compound as defined in claim 1 or 4 and a pharmacological acceptable carrier.
9. A pharmaceutical composition for increasing Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1) expression in a cell, comprising a compound as defined in claim 1 or 4 and a pharmacological acceptable carrier.
10. A pharmaceutical composition for treating a disease or condition characterized by decreased Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1), comprising a compound as defined in claim 1 or 4 and a pharmacological acceptable carrier, wherein the disease or condition characterized by decreased SHP-1 expression is cancer or osteoporosis.
11. A method for increasing Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1) expression in a cell, comprising contacting the cell with an effective amount of a compound as defined in claim 1 or 4 or a pharmaceutical composition of claim 8.
12. A method for treating a disease or condition characterized by decreased Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1) expression in a subject in need thereof, comprising administering to the subject an effective amount of a compound as defined in claim 1 or 4 or a pharmaceutical composition of claim 8, wherein the disease or condition characterized by decreased SHP-1 expression is cancer and osteoporosis.
13. The method of claim 12, wherein the cancer is hepatocellular carcinoma, leukemia, lung cancer, breast cancer, renal cancer, thyroid cancer colon, head and neck cancer.
14. A method of manufacturing a medicament including a compound as defined in claim 1 or 4 for treating a disease or condition characterized by decreased Src homology-2 containing protein tyrosine phosphatase-1 (SHP-1) expression, wherein the disease or condition characterized by decreased SHP-1 expression is cancer or osteoporosis.
15. The method of claim 14, wherein the cancer is hepatocellular carcinoma, leukemia, lung cancer, breast cancer, renal cancer, thyroid cancer colon, head and neck cancer.